These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13236742)

  • 1. [Treatment of diseases of the nervous system with patients hemolyzed blood with special reference to multiple sclerosis; preliminary communication].
    PRUSAK L
    Pol Tyg Lek (Wars); 1954 Nov; 9(46):1471-5. PubMed ID: 13236742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of results of the treatment of multiple sclerosis with hemolyzed blood].
    KOZIK M; WENDER M
    Pol Tyg Lek (Wars); 1957 Aug; 12(35):1352-6. PubMed ID: 13505224
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of multiple sclerosis using hemolyzed blood of the patient].
    PRUSAK L
    Neurol Neurochir Psychiatr Pol; 1958; 8(2):173-6. PubMed ID: 13566370
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins?].
    Schmidt S; Hohlfeld R
    Nervenarzt; 1995 Apr; 66(4):304-7. PubMed ID: 7783819
    [No Abstract]   [Full Text] [Related]  

  • 5. Caveat regarding immunoglobulin therapy in multiple sclerosis.
    Cross AH; Trotter JL; Hart WM
    Ann Neurol; 1993 Jun; 33(6):660-1. PubMed ID: 8338598
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of chronic diseases with polyvitamin therapy, with special reference to multiple sclerosis].
    GUTTMANN W
    Psychiatr Neurol Med Psychol (Leipz); 1953 Oct; 5(10):362-9. PubMed ID: 13145717
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary information on the Department of Neurology and multiple sclerosis patients at the State Hospital for Nervous and Mental Diseases at Rybnik].
    Dragon A
    Pol Tyg Lek; 1979 Jun; 34(24):955-7. PubMed ID: 471827
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
    Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
    Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multifocal therapy of multiple sclerosis, with special reference to lysozyme therapy].
    Rabassini A; Bernardi S
    Minerva Med; 1966 Mar; 57(24):1039-41. PubMed ID: 5930249
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the treatment of disseminated sclerosis with antireticular cytotoxic serum according to A. Bogomoletz].
    CENDROWSKI W
    Pol Tyg Lek (Wars); 1958 Jan; 13(4):134-7. PubMed ID: 13542267
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tests of cocarboxylase (berolase, Roche) in multiple sclerosis and several other nerve diseases].
    BARTOUSEK V; DUBANSKY B
    Med Monatsschr; 1957 Dec; 11(12):800-5. PubMed ID: 13503603
    [No Abstract]   [Full Text] [Related]  

  • 12. Galactose treatment of multiple sclerosis; a preliminary report.
    HARTSTEIN J; ULETT GA
    Dis Nerv Syst; 1957 Jul; 18(7 Part 1):255-8. PubMed ID: 13447785
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancing central nervous system remyelination in multiple sclerosis.
    Dubois-Dalcq M; Ffrench-Constant C; Franklin RJ
    Neuron; 2005 Oct; 48(1):9-12. PubMed ID: 16202704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: diagnosis and the management of acute relapses.
    Leary SM; Porter B; Thompson AJ
    Postgrad Med J; 2005 May; 81(955):302-8. PubMed ID: 15879043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?
    Hohlfeld R
    J Neurol Sci; 2008 Feb; 265(1-2):93-6. PubMed ID: 17459415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.
    Saccardi R; Tyndall A; Coghlan G; Denton C; Edan G; Emdin M; Farge D; Fassas A; Finke J; Furst D; Lassus M; Mancardi G; Miniati I; Mini E; Pagliai F; Passweg J; Pignone A; van Laar JM; Bocelli-Tyndall C; Matucci-Cerinic M
    Bone Marrow Transplant; 2004 Nov; 34(10):877-81. PubMed ID: 15517007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple sclerosis--symptoms, diagnosis and treatment].
    Elíasdóttir OJ; Olafsson E; Kjartansson O
    Laeknabladid; 2009 Sep; 95(9):583-9. PubMed ID: 19738293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of ACTH and cortisone treatment in some organic neurological cases.
    JONSSON B; VON REIS G; SAHLGREN E
    Acta Psychiatr Neurol Scand Suppl; 1951; 74():60-5. PubMed ID: 14902541
    [No Abstract]   [Full Text] [Related]  

  • 20. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
    Tischner D; Weishaupt A; van den Brandt J; Müller N; Beyersdorf N; Ip CW; Toyka KV; Hünig T; Gold R; Kerkau T; Reichardt HM
    Brain; 2006 Oct; 129(Pt 10):2635-47. PubMed ID: 16921176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.